FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Armin Szegedi

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Physiology

Genotype

Procedures

Genes & Molecular Sequences

Co-author Network

Publications

TOP 3
Ion Anghelescu; Christoph Klawe; Peter Singer; Christoph Fehr; Christoph Hiemke; Arnim Quante; Francesca Regen; Norbert Dahmen; Armin Szegedi
Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene.
Gunter Schumann; Monika Johann; Josef Frank; Ulrich W Preuss; Norbert Dahmen; Manfred Laucht; Marcella Rietschel; Dan Rujescu; Anbarasu Lourdusamy; Toni-Kim Clarke; Kristina Krause; Anne Dyer; Martin Depner; Stefan Wellek; Jens Treutlein; Armin Szegedi; Ina Giegling; Sven Cichon; Dorothea Blomeyer; Andreas Heinz; Simon Heath; Mark Lathrop; Norbert Wodarz; Michael Soyka; Rainer Spanagel; Karl Mann
Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior.
André Tadić; Dan Rujescu; Matthias J Müller; Ralf Kohnen; Hans H Stassen; Armin Szegedi; Norbert Dahmen
Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Armin Szegedi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Ion Anghelescu; Christoph Klawe; Peter Singer; Christoph Fehr; Christoph Hiemke; Arnim Quante; Francesca Regen; Norbert Dahmen; Armin Szegedi
Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(2 Pt 2):382-9.
2008: Gunter Schumann; Monika Johann; Josef Frank; Ulrich W Preuss; Norbert Dahmen; Manfred Laucht; Marcella Rietschel; Dan Rujescu; Anbarasu Lourdusamy; Toni-Kim Clarke; Kristina Krause; Anne Dyer; Martin Depner; Stefan Wellek; Jens Treutlein; Armin Szegedi; Ina Giegling; Sven Cichon; Dorothea Blomeyer; Andreas Heinz; Simon Heath; Mark Lathrop; Norbert Wodarz; Michael Soyka; Rainer Spanagel; Karl Mann
Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior.
Archives of general psychiatry 2008;65(7):826-38.
2008: André Tadić; Dan Rujescu; Matthias J Müller; Ralf Kohnen; Hans H Stassen; Armin Szegedi; Norbert Dahmen
Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression.
Neuropsychiatric disease and treatment 2008;4(1):269-76.
2007: André Tadić; Dan Rujescu; Matthias J Müller; Ralf Kohnen; Hans H Stassen; Norbert Dahmen; Armin Szegedi
A monoamine oxidase B gene variant and short-term antidepressant treatment response.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(7):1370-7.
2007: André Tadić; Matthias J Müller; Dan Rujescu; Ralf Kohnen; Hans H Stassen; Norbert Dahmen; Armin Szegedi
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(3):325-31.
2007: Siegfried Kasper; Ion Anghelescu; Armin Szegedi; Angelika Dienel; Meinhard Kieser
Placebo controlled continuation treatment with Hypericum extract WS 5570 after recovery from a mild or moderate depressive episode.
Wiener medizinische Wochenschrift (1946) 2007;157(13-14):362-6.
2006: Ion Anghelescu; Ralf Kohnen; Armin Szegedi; S Klement; Meinhard Kieser
Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
Pharmacopsychiatry 2006;39(6):213-9.
2006: Otto Benkert; Armin Szegedi; Michael Philipp; Ralf Kohnen; Claus Heinrich; Anja Heukels; Monique van der Vegte-Senden; Ross A Baker; John H Simmons; Albert-Jan Schutte
Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
Journal of clinical psychopharmacology 2006;26(1):75-8.
2006: Christoph Fehr; Thomas Sander; André Tadic; Kirsten P Lenzen; Ion Anghelescu; Christoph Klawe; Norbert Dahmen; Lutz G Schmidt; Armin Szegedi
Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis.
Psychiatric genetics 2006;16(1):9-17.
2006: Siegfried Kasper; Ion Anghelescu; Armin Szegedi; Angelika Dienel; Meinhard Kieser
Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
BMC medicine 2006;4():14.
2005: Ion Anghelescu; Christoph Klawe; Christoph Fehr; Peter Singer; Alexandra Schleicher; Hubertus Himmerich; Christoph Hiemke; Norbert Dahmen; Armin Szegedi
The TPH intron 7 A218C polymorphism and TCI dimension scores in alcohol-dependent patients: hints to nonspecific psychopathology.
Addictive behaviors 2005;30(6):1135-43.
2005: Armin Szegedi; Natascha Schwertfeger
Mirtazapine: a review of its clinical efficacy and tolerability.
Expert opinion on pharmacotherapy 2005;6(4):631-41.
2005: André Tadic; Norbert Dahmen; Armin Szegedi; Dan Rujescu; Ina Giegling; Gabriele Koller; Ion Anghelescu; Christoph Fehr; Christoph Klawe; Ulrich W Preuss; Thomas Sander; Mohammad R Toliat; Peter Singer; Brigitta Bondy; Michael Soyka
Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremens.
European archives of psychiatry and clinical neuroscience 2005;255(2):129-35.
2005: Armin Szegedi; Ralf Kohnen; Angelika Dienel; Meinhard Kieser
Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.
BMJ (Clinical research ed.) 2005;330(7490):503.
2005: Norbert Dahmen; Markus Völp; Peter Singer; Christoph Hiemke; Armin Szegedi
Tyrosine hydroxylase Val-81-Met polymorphism associated with early-onset alcoholism.
Psychiatric genetics 2005;15(1):13-6.
2005: Matthias J Müller; Armin Scheurich; Hermann Wetzel; Armin Szegedi; Martin Hautzinger
Sequentially adjusted randomization to force balance in controlled trials with unknown prevalence of covariates: application to alcoholism research.
Alcohol and alcoholism (Oxford, Oxfordshire) 2005;40(2):124-31.
2005: Dan Rujescu; Michael Soyka; Norbert Dahmen; Ulrich W Preuss; Annette M Hartmann; Ina Giegling; Gabriele Koller; Brigitta Bondy; Hans-Jürgen Möller; Armin Szegedi
GRIN1 locus may modify the susceptibility to seizures during alcohol withdrawal.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2005;133B(1):85-7.
2005: Armin Scheurich; Matthias J Müller; Ion Anghelescu; Bernd Lörch; M Dreher; Martin Hautzinger; Armin Szegedi
Reliability and validity of the form 90 interview.
European addiction research 2005;11(1):50-6.
2005: Armin Szegedi; Dan Rujescu; André Tadic; Matthias J Müller; Ralf Kohnen; Hans H Stassen; Norbert Dahmen
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.
The pharmacogenomics journal 2005;5(1):49-53.
2004: Hermann Wetzel; Armin Szegedi; Armin Scheurich; Bernd Lörch; Peter Singer; Detlef Schläfke; Helmut Sittinger; Thomas Wobrock; Matthias J Müller; Ion Anghelescu; Martin Hautzinger
Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study.
The Journal of clinical psychiatry 2004;65(10):1406-13.
2004: Armin Scheurich; Matthias J Müller; Armin Szegedi; Ion Anghelescu; Christoph Klawe; Bernd Lörch; Bernd Kappis; H-G Bialonski; S Haas; Martin Hautzinger
Neuropsychological status of alcohol-dependent patients: increased performance through goal-setting instructions.
Alcohol and alcoholism (Oxford, Oxfordshire) 2004;39(2):119-25.
2003: Gunter Schumann; Dan Rujescu; Christian Kissling; Michael Soyka; Norbert Dahmen; Ulrich W Preuss; Stefan Wieman; Martin Depner; Stefan Wellek; Jesús Lascorz; Brigitta Bondy; Ina Giegling; Ion Anghelescu; Michael S Cowen; Annemarie Poustka; Rainer Spanagel; Karl Mann; Fritz A Henn; Armin Szegedi
Analysis of genetic variations of protein tyrosine kinase fyn and their association with alcohol dependence in two independent cohorts.
Biological psychiatry 2003;54(12):1422-6.
2003: Matthias J Müller; Hubertus Himmerich; Barbara Kienzle; Armin Szegedi
Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS).
Journal of affective disorders 2003;77(3):255-60.
2003: Hubertus Himmerich; Armin Szegedi; Christoph Klawe; Ion Anghelescu; Matthias J Müller
Distigmine bromide induced acute psychotic disorder in a patient with multiple sclerosis.
European psychiatry : the journal of the Association of European Psychiatrists 2003;18(6):318-9.
2003: Armin Szegedi; Matthias J Müller; Ion Anghelescu; Christoph Klawe; Ralf Kohnen; Otto Benkert
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
The Journal of clinical psychiatry 2003;64(4):413-20.
2003: André Tadic; Dan Rujescu; Armin Szegedi; Ina Giegling; Peter Singer; Hans-Jürgen Möller; Norbert Dahmen
Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;117B(1):1-6.
2003: Christian Lange-Asschenfeldt; Matthias J Müller; Armin Szegedi; Ion Anghelescu; Christoph Klawe; Hermann Wetzel
Symptom-triggered versus standard chlormethiazole treatment of inpatient alcohol withdrawal: clinical implications from a chart analysis.
European addiction research 2003;9(1):1-7.
2002: Eugen Davids; Matthias J Müller; Nicole Rollmann; Martin Burkart; Eva Regier-Klein; Armin Szegedi; Otto Benkert; Wolgang Maier
Syndrome profiles in alcoholism and panic disorder with or without agoraphobia: an explorative family study.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(6):1079-87.
2002: Ion Anghelescu; Christoph Klawe; Armin Szegedi
Add-on combination and maintenance treatment: case series of five obese patients with different eating behavior.
Journal of clinical psychopharmacology 2002;22(5):521-4.
2002: Otto Benkert; M Muller; Armin Szegedi
An overview of the clinical efficacy of mirtazapine.
Human psychopharmacology 2002;17 Suppl 1():S23-6.
2002: Matthias J Müller; Armin Szegedi
Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials.
Journal of clinical psychopharmacology 2002;22(3):318-25.
2001: Ion Anghelescu; Christoph Klawe; Hubertus Himmerich; Armin Szegedi
Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction.
Journal of clinical psychopharmacology 2001;21(4):462-4.
2001: Christoph Fehr; A Schleicher; Armin Szegedi; Ion Anghelescu; Christoph Klawe; Christoph Hiemke; Norbert Dahmen
Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy.
Progress in neuro-psychopharmacology & biological psychiatry 2001;25(5):965-82.
2001: Ion Anghelescu; Sabine Germeyer; Matthias J Müller; Christoph Klawe; Peter Singer; Norbert Dahmen; Hermann Wetzel; Hubertus Himmerich; Armin Szegedi
No association between the dopamine d2 receptor taqi a1 allele and earlier age of onset of alcohol dependence according to different specified criteria.
Alcoholism, clinical and experimental research 2001;25(6):805-9.
2001: Christoph Fehr; Norbert Dahmen; Christoph Klawe; M Eicke; Armin Szegedi
Piracetam in the treatment of tardive dyskinesia and akathisia: a case report.
Journal of clinical psychopharmacology 2001;21(2):248-9.
2001: Hubertus Himmerich; Ion Anghelescu; Christoph Klawe; Armin Szegedi
Vitamin B12 and hepatic enzyme serum levels correlate in male alcohol-dependent patients.
Alcohol and alcoholism (Oxford, Oxfordshire) 2001;36(1):26-8.
2000: Christoph Fehr; N Grintschuk; Armin Szegedi; Ion Anghelescu; Christoph Klawe; Peter Singer; Christoph Hiemke; Norbert Dahmen
The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy.
Psychiatry research 2000;97(1):1-10.
2000: Armin Scheurich; Matthias J Müller; Hermann Wetzel; Ion Anghelescu; Christoph Klawe; A Ruppe; Bernd Lörch; Hubertus Himmerich; M Heidenreich; G Schmid; Martin Hautzinger; Armin Szegedi
Reliability and validity of the German version of the European Addiction Severity Index (EuropASI).
Journal of studies on alcohol 2000;61(6):916-9.
2000: Matthias J Müller; Armin Szegedi; Hermann Wetzel; Otto Benkert
Moderate and severe depression. Gradations for the Montgomery-Asberg Depression Rating Scale.
Journal of affective disorders 2000;60(2):137-40.
2000: Otto Benkert; Armin Szegedi; Ralf Kohnen
Mirtazapine compared with paroxetine in major depression.
The Journal of clinical psychiatry 2000;61(9):656-63.
2000: Christoph Fehr; Armin Szegedi; Ion Anghelescu; Christoph Klawe; Christoph Hiemke; Norbert Dahmen
Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study.
Psychiatric genetics 2000;10(2):59-65.
2000: Norbert Dahmen; T Pauly; Armin Szegedi; Hermann Wetzel; Ion Anghelescu; K Ferdinand; Christoph Hiemke
Adenylyl cyclase activity is increased in younger, but decreased in older, alcoholic patients after detoxification.
Alcohol and alcoholism (Oxford, Oxfordshire) 2000;35(3):249-54.
2000: B Loerch; Armin Szegedi; Ralf Kohnen; Otto Benkert
The primary care evaluation of mental disorders (PRIME-MD), German version: a comparison with the CIDI.
Journal of psychiatric research 2000;34(3):211-20.
2000: Armin Szegedi; Matthias J Müller; Hubertus Himmerich; Ion Anghelescu; Hermann Wetzel
Carbohydrate-deficient transferrin (CDT) and HDL cholesterol (HDL) are highly correlated in male alcohol dependent patients.
Alcoholism, clinical and experimental research 2000;24(4):497-500.
2000: Dan Rujescu; Ina Giegling; Norbert Dahmen; Armin Szegedi; Ion Anghelescu; Anton Gietl; M Schäfer; Florian Müller-Siecheneder; Brigitta Bondy; Hans-Jürgen Möller
Association study of suicidal behavior and affective disorders with a genetic polymorphism in ABCG1, a positional candidate on chromosome 21q22.3.
Neuropsychobiology 2000;42 Suppl 1():22-5.
2000: Armin Szegedi; Bernd Lörch; Armin Scheurich; A Ruppe; Martin Hautzinger; Hermann Wetzel
Cue exposure in alcohol dependent patients: preliminary evidence for different types of cue reactivity.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(6):721-30.
1999: Armin Szegedi; Ion Anghelescu; J Wiesner; S Schlegel; Harald Weigmann; Sebastian Härtter; Christoph Hiemke; Hermann Wetzel
Addition of low-dose fluvoxamine to low-dose clozapine monotherapy in schizophrenia: drug monitoring and tolerability data from a prospective clinical trial.
Pharmacopsychiatry 1999;32(4):148-53.
1999: T Pauly; Norbert Dahmen; Armin Szegedi; Hermann Wetzel; G F Böl; K Ferdinand; Christoph Hiemke
Blood ethanol levels and adenylyl cyclase activity in lymphocytes of alcoholic patients.
Biological psychiatry 1999;45(4):489-93.
1998: Ion Anghelescu; Armin Szegedi; S Schlegel; Harald Weigmann; Christoph Hiemke; Hermann Wetzel
Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1998;8(4):315-20.
1998: Armin Szegedi; Ion Anghelescu; T Pauly; Norbert Dahmen; Matthias J Müller; Hermann Wetzel; Christoph Hiemke
Activity of the adenylyl cyclase in lymphocytes of male alcoholic patients is state dependent.
Alcoholism, clinical and experimental research 1998;22(9):2073-9.
1998: Matthias J Müller; Wolfgang Rossbach; P Dannigkeit; Florian Müller-Siecheneder; Armin Szegedi; Hermann Wetzel
Evaluation of standardized rater training for the Positive and Negative Syndrome Scale (PANSS).
Schizophrenia research 1998;32(3):151-60.
1998: Florian Müller-Siecheneder; Matthias J Müller; A Hillert; Armin Szegedi; Hermann Wetzel; Otto Benkert
Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome.
Journal of clinical psychopharmacology 1998;18(2):111-20.
1998: Hermann Wetzel; Ion Anghelescu; Armin Szegedi; J Wiesner; Harald Weigmann; S Härter; Christoph Hiemke
Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
Journal of clinical psychopharmacology 1998;18(1):2-9.
1997: Armin Szegedi; Hermann Wetzel; D Angersbach; M Philipp; Otto Benkert
Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline.
Journal of affective disorders 1997;45(3):167-78.
1997: Armin Szegedi; Hermann Wetzel; D Angersbach; G C Dunbar; H Schwarze; M Philipp; Otto Benkert
A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
Pharmacopsychiatry 1997;30(3):97-105.
1997: Otto Benkert; Armin Szegedi; Hermann Wetzel; H J Staab; W Meister; M Philipp
Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response.
Acta psychiatrica Scandinavica 1997;95(4):288-96.
1996: Otto Benkert; Armin Szegedi; Hermann Wetzel
Minimum effective dose for antidepressants--an obligatory requirement for antidepressant drug evaluation?
International clinical psychopharmacology 1996;11(3):177-85.
1996: Armin Szegedi; Hermann Wetzel; M Leal; Sebastian Härtter; Christoph Hiemke
Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.
The Journal of clinical psychiatry 1996;57(6):257-64.
1995: Hermann Wetzel; Armin Szegedi; C Hain; J Wiesner; S Schlegel; Otto Benkert
Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters.
Psychopharmacology 1995;119(2):231-8.
1995: Armin Szegedi; J Wiesner; Christoph Hiemke
Improved efficacy and fewer side effects under clozapine treatment after addition of fluvoxamine.
Journal of clinical psychopharmacology 1995;15(2):141-3.
1994: Sebastian Härtter; B Hermes; Armin Szegedi; Christoph Hiemke
Automated determination of paroxetine and its main metabolite by column switching and on-line high-performance liquid chromatography.
Therapeutic drug monitoring 1994;16(4):400-6.
1993: Otto Benkert; Hermann Wetzel; Armin Szegedi
Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
International clinical psychopharmacology 1993;8 Suppl 1():3-14.